Plus Therapeutics (PSTV) EBIT Margin Growth (1y) (2012 - 2026)
Plus Therapeutics (PSTV) EBIT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Plus Therapeutics |
34.26 Mn |
19.15 Mn |
- |
-35,861.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-35,861.00 |
| Dec 31, 2025 |
-14,384.00 |
| Sep 30, 2025 |
-5,991.00 |
| Jun 30, 2025 |
17,841.00 |
| Mar 31, 2025 |
-13,718.00 |
| Dec 31, 2024 |
1,763.00 |
| Sep 30, 2024 |
-18,703.00 |
| Jun 30, 2024 |
-20,869.00 |
| Mar 31, 2024 |
74,768.00 |
| Dec 31, 2023 |
409,357.00 |
| Sep 30, 2023 |
690,420.00 |
| Mar 31, 2019 |
28,724.00 |
| Dec 31, 2018 |
41,402.00 |
| Sep 30, 2018 |
67,042.00 |
| Jun 30, 2018 |
29,626.00 |
| Mar 31, 2018 |
61,091.00 |
| Dec 31, 2017 |
-30,345.00 |
| Sep 30, 2017 |
-27,375.00 |
| Jun 30, 2017 |
-2,320.00 |
| Mar 31, 2017 |
-82,389.00 |
